✦ LIBER ✦

Phase II study of edatrexate in advanced head and neck cancer

✍ Scribed by J. Philip Kuebler; Jacqueline Benedetti; David E. Schuller; John Ensley; Steven M. Grunberg; Michael J. Muirhead; Kathryn E. Richert-Boe; Manly E. Marshall

Publisher: Springer US
Year: 1994
Tongue: English
Weight: 279 KB
Volume: 12
Category: Article
ISSN: 0167-6997
DOI: 10.1007/bf00873052

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II study of fazarabine in advanced

Phase II study of fazarabine in advanced head and neck cancer

✍ J. Philip Kuebler; Barbara Metch; David E. Schuller; Michael Keppen; Harry E. Hy 📂 Article 📅 1991 🏛 Springer US 🌐 English ⚖ 138 KB

Phase II trial of N-methylformamide in a

Phase II trial of N-methylformamide in advanced head and neck cancer

✍ Walter C. Vogel; Arlene A Forastiere; Ronald B. Natale; Bonnie J. Takasugi; Gary 📂 Article 📅 1987 🏛 Springer US 🌐 English ⚖ 228 KB

A phase II study of piritrexim in patien

A phase II study of piritrexim in patients with advanced squamous head and neck cancer

✍ Wu-Ching Uen; Andrew T. Huang; Robert Mennel; Stephen E. Jones; Monica B. Spauld 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 347 KB 👁 3 views

Piritrexim (PTX) is a newly developed lipid-soluble folate antagonist that crosses the cell membrane by a simple, rapid, carrier-independent diffusion process. A Phase II study was conducted to evaluate the activity of PTX in 34 patients with previously chemotherapy-naive squamous cell cancer of the

Phase ii trial of etoposide and doxorubi

Phase ii trial of etoposide and doxorubicin in advanced head and neck cancer

✍ Gradishar, William J. ;Vokes, Everett E. ;Kies, Merrill S. 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 388 KB

## Abstract In an effort to improve the response rate of patients with advanced head and neck cancer, a clinical trial combining two infrequently studied drugs was conducted. Twelve patients with squamous cell carcinoma of the head and neck were treated with 3‐day continuous infusions of etoposide

A phase II study of mitoxantrone in adva

A phase II study of mitoxantrone in advanced squamous cell cancer of the head and neck

✍ H. Wheeler; R. L. Woods; J. Page; J. Levi 📂 Article 📅 1990 🏛 Springer US 🌐 English ⚖ 186 KB

Twenty patients with advanced squamous cell carcinomas (SCC) of the head and neck were entered into a phase II study of mitoxantrone at a dosage of either 12 mg/m2 or 14 mg/m2 given at 3 weekly intervals. None of the patients had received prior chemotherapy. One patient had a partial remission. Two

Phase II trial of methylglyoxal bis (gua

Phase II trial of methylglyoxal bis (guanylhydrazone) (MGBG) in advanced head and neck cancer

✍ Arlene A. Forastiere; Ronald B. Natale; Richard R. Wheeler 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 343 KB 👁 3 views